C07D 283/00
Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom
Official title: Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00
C07D283/00 (Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C07D- Granted patents
- 4
- Published applications
- 7
- Assignees
- 4
- Inventors
- 20
- Latest grant
- 27 Aug 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Azepane derivatives and methods of treating hepatitis B infections27 Aug 2019US 10,392,349 B2Novira Therapeutics, Inc.
- Azepane derivatives and methods of treating hepatitis B infections23 Jan 2018US 9,873,671 B2Novira Therapeutics, Inc.
- Azepane derivatives and methods of treating hepatitis B infections29 Nov 2016US 9,505,722 B2Novira Therapeutics, Inc.
- Azepane derivatives and methods of treating hepatitis B infections27 Oct 2015US 9,169,212 B2Novira Therapeutics, Inc.
- Actinic ray-sensitive or radiation-sensitive resin composition, pattern forming method, resist film, and method for manufacturing electronic device17 Mar 2022US 2022/0082938 A1FUJIFILM Corporation
- Azepane derivatives and methods of treating hepatitis b infections17 Jan 2019US 2019/0016682 A1Novira Therapeutics, Inc.
- Heteroaryl compounds comprising nitrogen and use thereof26 Oct 2017US 2017/0305861 A1ImmunoMet Therapeutics Inc.
- Azepane derivatives and methods of treating hepatitis b infections19 Jan 2017US 2017/0015629 A1Novira Therapeutics, Inc.
- Azepane derivatives and methods of treating hepatitis b infections13 Aug 2015US 2015/0225355 A1Novira Therapeutics, Inc.
Most cited
By later US patents
- Azepane derivatives and methods of treating hepatitis B infections28US 9,169,212 B2Novira Therapeutics, Inc. · 2015
- Azepane derivatives and methods of treating hepatitis B infections24US 9,505,722 B2Novira Therapeutics, Inc. · 2016
- Azepane derivatives and methods of treating hepatitis B infections1US 9,873,671 B2Novira Therapeutics, Inc. · 2018